Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine in Huntington's Disease (CREST-X)
NCT01412151Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2005
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine in Huntington's disease (HD), sponsored by Massachusetts General Hospital. Started Apr 2005; status: completed.
02
Drugs
creatine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT01412151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412151.